Former Johnson & Johnson Executive Appointed to Lead Clinical Strategy for Horizon Surgical Systems' Ophthalmic Robot
Horizon Surgical Systems
Developer of Advanced Microsurgical Robotics
【Viewpoint · Ophthalmology Industry Navigation】
Major Events Monthly Report | Editor's Recommended Article
Winning Atlas· Centralized Procurement Scaling Up | Ophthalmic Optometry Column
Recently, surgical robot companiesHorizon Surgical SystemsComplete a key personnel appointment——Official AppointmentFormer Global Medical Affairs Head of Johnson & Johnson Vision, Dr. Rajesh K. RajpalChief Strategy and Medical Officer（CSO & CMO）. This decision is regarded by the industry as an important strategic deployment for the company to advance clinical trials and market expansion of its Polaris ophthalmic surgical robot system.
Dr. Rajpal has over two decades of extensive experience in the field of ophthalmic medical devices, with a career spanning clinical practice, medical affairs, and product strategy. This personnel change signals that Horizon Surgical Systems, Inc. is set to advance in the field of ophthalmic surgical robotics.Accelerate its clinical layout and industrialization process。
Horizon Surgical Systems, Inc.Polaris Surgical Robot SystemThrough high-precision robotic arms, real-time imaging, and AI-assisted decision-making, Horizon Surgical Systems aims to enhance the standardization and consistency of ophthalmic surgeries, particularly in the field of cataract surgery, where there is enormous global demand. With the completion of Series A financing and the addition of Dr. Rajpal, Horizon Surgical Systems has not only laid a solid foundation for upcoming clinical trials and FDA approval but also gained a competitive edge in global market expansion.
# From the Operating Room to the Industry: A Strategist
Dr. Rajpal’s career trajectory clearly demonstrates his successful transition from a top-tier surgeon to a strategic decision-maker in the healthcare industry. As one of the earliest specialists to perform refractive laser surgery in Washington, D.C., he has not only accumulated extensive first-hand clinical experience but also gained a profound understanding of the core challenges and unmet clinical needs in ophthalmic surgery.
During her tenure at Johnson & Johnson Vision, Dr. RajpalLed the global clinical strategy planning and execution for several key ophthalmic devices.`, which has enabled him to accumulate clinical development and global market expansion experience at the level of multinational medical device enterprises.`
Subsequently, during his tenure as Chief Medical Officer at Avedro/Glaukos, he was involved throughout the entire process.Participated in and promoted the clinical trial design and regulatory registration of multiple innovative ophthalmic treatment technologies.This experience has given him unique insights into the complete pathway of innovative medical devices from the laboratory to clinical application.
This unique composite background——Proficient in both clinical practice and industry operations——This makes Dr. Rajpal a highly sought-after talent for innovative companies like Horizon. He not only accurately grasps the clinical value direction of product development but also establishes development paths that meet regulatory requirements and possess commercial feasibility.
# Polaris System: Targeting Pain Points in Ophthalmic Surgery
Horizon Surgical Systems' Polaris surgical robot attempts to address three long-standing pain points in ophthalmic surgery:Surgical precision is affected by individual factors of the doctor, consistency of postoperative results is insufficient, and there is an uneven distribution of surgical resources globally.。
Polaris's design concept is highly aligned with market demands, aiming to enhance the standardization and consistency of ophthalmic surgeries through high-precision robotic arms, intraoperative imaging, and AI-based intelligent decision-making.
Solving Precision Differences: The Core Advantage of High-Precision Robotic Arms
The Polaris system, by adopting high-precision robotic arms, is able toMicron-level precisionStably perform surgical actions, significantly reducing errors caused by hand tremors and fatigue.
Intraoperative Imaging and Real-Time Decision Making: Enhancing Visibility and Judgment
Another major advantage of Polaris is itsIntraoperative 3D Imaging System, capable of constructing three-dimensional images of intraoperative tissue in real time,Can help doctors identify intraocular structures and lesion areas,Provide surgical path suggestions for doctors.
AI Intelligent Assistance: Enhancing Standardization and Consistency
Polaris SystemIntroductionAI Technology, real-time analysis of the surgical environment, AI algorithms can help doctors optimize surgical trajectories, detect anomalies, and provide timely feedback. This intelligent assistance approach streamlines the surgical operation process.Standardization, reduce human errors during surgery, and improve the consistency of surgical outcomes.
From "Assistive" to "Intelligent": The Design Philosophy of Polaris
Polaris is not a fully automated end-to-end surgical robot, but ratherEmphasizing Intelligent Assistance, aiming to assist doctors in completing standardized operations. This design concept not only aligns with the acceptance of ophthalmologists but also better meets the requirements of regulatory authorities.
# Executive Changes and Strategic Adjustments
In February 2025, ForSight Robotics announced,Dr. Fred Moll, Co-founder of Intuitive Surgical, Joins Its Board of DirectorsIntuitive Surgical is the company behind the da Vinci Surgical System, and Dr. Fred Moll, as a co-founder, is known as the "Father of Surgical Robotics."ForSight RoboticsIt is his first time serving as a consultant for a surgical robotics company in the ophthalmology field.
In July 2023, ForSight Robotics announcedAppointment of Former Medtronic Executive Sharon Levita as Chief Financial Officer (CFO)ForSight Robotics plans to have Levita lead its strategic and financial operations department, focusing on advancing business strategy, expanding strategic partnerships, and managing financial and growth objectives.Levita has more than 20 years of experience in the medical technology industry and has served as the business development and strategy leader for Medtronic's Cranial and Spinal Technologies operations.
Forsight's ORYOM Surgical Robotic System, isThe First Hybrid Intraocular Robotic Ophthalmic Platform，With 14 micro degrees of freedom, it is capable of performing delicate tasks, and its hybrid motion structure allows access to nearly any area within the human eye.
# Company Profile
GOC2025
Ophthalmology Solutions Case
Research on Ophthalmic Instruments Industry
